What stage is invasive mammary carcinoma?
What is stage 2 breast cancer? Also known as invasive breast cancer, the tumor in this stage measures between 2 cm to 5 cm, or the cancer has spread to the lymph nodes under the arm on the same side as the breast cancer. Stage 2 breast cancer indicates a slightly more advanced form of the disease.
What is the survival rate for invasive mammary carcinoma?
The average 10-year survival rate for women with non-metastatic invasive breast cancer is 84%. If the invasive breast cancer is located only in the breast, the 5-year survival rate of women with this disease is 99%. Sixty-three percent (63%) of women with breast cancer are diagnosed with this stage.
Is invasive carcinoma dangerous?
Lobular carcinoma in situ (LCIS).
If you’ve been diagnosed with LCIS — abnormal cells confined within breast lobules — your risk of developing invasive cancer in either breast is increased. LCIS isn’t cancer, but is an indication of increased risk of breast cancer of any type.
How common is invasive mammary carcinoma?
This is the most common type of breast cancer. About 8 in 10 invasive breast cancers are invasive (or infiltrating) ductal carcinomas (IDC). IDC starts in the cells that line a milk duct in the breast.
How is invasive mammary carcinoma treated?
Invasive mammary carcinoma is treated with a lumpectomy or mastectomy, depending on the size and location of the tumor. Your oncology team also may recommend chemotherapy and/or radiation, hormonal therapy or biologic targeted therapy.
Is invasive mammary carcinoma the same as invasive ductal carcinoma?
Another term for invasive ductal carcinoma is invasive mammary carcinoma of no special type, because it is the most common type of breast carcinoma. Both invasive ductal carcinomas and invasive lobular carcinomas arise from the cells lining the ducts and lobules in the breast.
What does invasive carcinoma mean?
(in-VAY-siv KAN-ser) Cancer that has spread beyond the layer of tissue in which it developed and is growing into surrounding, healthy tissues. Also called infiltrating cancer.
Should I be worried about architectural distortion?
Architectural distortion, the non-mass but potentially ominous clinical feature observed in many breast imaging procedures, is less likely to signal malignancy when it’s detected on screening mammography rather than diagnostic mammography or when it doesn’t correlate with a subsequent targeted ultrasound exam.